Videoteca
Galería
Centro EduPoen
Nuestro espacio
Simulador quirúrgico
Laboratorios POEN
Contacto
Videoteca
Galería
Centro EduPoen
Nuestro espacio
Simulador quirúrgico
Laboratorios POEN
Contacto
del Papa Melina
El Hialuronato de Sodio protege de la toxicidad corneal del BAKen un modelo in vivo
Ver estudio
(ARVO 2023) Sodium hyaluronate improves corneal reinnervation and epithelial healingin anin vivo benzalkonium chloride (BAK)-induced toxicity model
Ver estudio
Hyaluronate Protects From Benzalkonium Chloride-InducedOcular Surface Toxicity
Ver estudio
(EGS 2022) In vitro evaluation of sodium hyaluronate protective effect against benzalkonium chloride toxicity
Ver estudio
(EVER 2022) In vitro evaluation of sodium hyaluronate protective effect against benzalkonium chloride toxicity
Ver estudio
Efecto del hialuronato de sodio 0,4% sobre la regeneración nerviosa corneal en presencia del cloruro de benzalconio
Ver estudio
Efficacy and Toxicity Evaluation of Bepotastine Besilate 1.5% Preservative-Free Eye Drops Vs Olopatadine Hydrochloride 0.2% Bak-Preserved Eye Drops in Patients with Allergic Conjunctivitis
Ver estudio
Evaluation of the osmoprotective and bioprotective effect of trehalose 3%
Ver estudio
(WGC 2023) Sodium hyaluronate improves corneal reinnervation and epithelial healingin anin vivo benzalkonium chloride (BAK)-induced toxicity model
Ver estudio
Efficacy and Tolerability of a New Latanoprost 0.005%BAK-Free Nanoemulsion: A Nonrandomized Open-Label Trial
Ver estudio
Evaluación in vitro del efecto protector del hialuronato de sodio frente a la toxicidad inducida por el cloruro de benzalconio
Ver estudio
A Comparative Study of Difluprednate 0.05% Nanoemulsion Vs Prednisolone Acetate 1% + Phenylephrine 0.12% Suspension on Postoperative Inflammation Treatment Following Cataract Surgery
Ver estudio
Cytotoxicity evaluation of a novel latanoprost 0.005% nanoemulsion
Ver estudio
A novel ophthalmic latanoprost 0.005% nanoemulsion: a cytotoxicity study
Ver estudio
Difluprednate 0.05% twice a day vs prednisolone acetate 1% 4 times a day forcataract postsurgical inflammation treatment:noninferiority trial
Ver estudio
Evaluation of the osmoprotective and bioprotective effect of trehalose 3%
Ver estudio
Welcome Back!
Sign in to your account
Nombre de usuario o correo electrónico
Contraseña
Recuérdame